Delivery Order SPE2DB20D3103-SPE2DB23FL7G7
Award Date 11/29/22
Potential Completion Date 11/30/22
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,554.79 firm fixed-price delivery order contract is for the supply of 4,567,282,823 units of 30 mg Oseltamivir Phosphate capsules. The contract has a ceiling value of $3,554.79 and runs through February 18, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,732.12 firm fixed-price delivery order is for the supply of 4,558,866,552 units of the drug Oseltamivir Phosphate 30 mg capsules, with an ultimate completion date of October 25, 2022. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,035.78 firm fixed-price delivery order contract is for the supply of 4,562,562,995 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. This appears to be a task order under a larger Indefinite Delivery Contract...
- This federal contract award, valued at $1,238.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through December 2025. This single-award IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $1,328.80 and an ultimate completion date of January 7, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,425.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of 4,564,007,468 units of Oseltamivir Phosphate 75mg capsules. The contract has an ultimate completion date of March 20, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen, a for-profit...
- The federal contract award is for the delivery of 4,563,327,071 units of the pharmaceutical product Oseltamivir Phosphate 75 mg Capsules. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,188.72 and an ultimate completion date of January 16, 2024. The contract is not designated with a set-aside and appears to be an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.64 firm fixed-price delivery order is for the supply of 4,563,651,026 units of the drug Oseltamivir Phosphate 75 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.05 delivery order contract is for the supply of 4,567,584,763 units of the drug Oseltamivir Phosphate 30 mg capsules. The contract has a period of performance through March 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award, valued at $2,124.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Oseltamivir Phosphate 30 mg capsules. It is a Firm Fixed Price contract with an ultimate completion date of January 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a larger Indefinite...